Hyperparathyroidism and fibrocystic osteitis: what is important not to miss

• Larisa A. Bugova
• Artur B. Khadzugov

Abstract

In a complex clinical case, a high frequency of detection of differential diagnosis, control of the level of parathyroid hormone in the detection of hypercalcemia was clearly demonstrated. Due to untimely control of cholesterol levels in patients, osteoporosis progressed with the formation of fibrous osteitis, insufficient differential diagnosis led to recommendations for «surgical treatment» of bone formation. The progression of fibrous osteitis includes the asymptomatic course of hyperparathyroidism at the onset of the disease.

Keywords:hyperparathyroidism; fibrous osteitis; hypercalcemia; urolithiasis

References

1. Eastell R., Brandi M.L., Costa A.G., D’Amour P., et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop [published correction appears in J Clin Endocrinol Metab. 2015 May;100(5):2137]. J Clin Endocrinol Metab. 2014; 99 (10): 3570–9. DOI: https://doi.org/10.1210/jc.2014-1414

2. Cope O. The study of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med. 1966; 274 (21): 1174–82. DOI: https://doi.org/10.1056/NEJM196605262742105

3. Press D.M., Siperstein A.E., Berber E., et al. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery. 2013; 154 (6): 1232–8. DOI: https://doi.org/10.1016/j.surg.2013.06.051

4. Rao S.D., Frame B., Miller M.J., Kleerekoper M., et al. Hyperparathyroidism following head and neck irradiation. Arch Intern Med. 1980; 140 (2): 205–7. DOI: https://doi.org/10.1001/archinte.1980.00330140063019

5. Silverberg S.J., Shane E., Jacobs T.P., Siris E., Bilezikian J.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery [published correction appears in N Engl J Med. 2000; 342 (2): 144]. N Engl J Med. 1999; 341 (17): 1249–55. DOI: https://doi.org/10.1056/NEJM199910213411701

6. Brown E.M. Role of the calcium-sensing receptor in extracellular calcium homeostasis. Best Pract Res Clin Endocrinol Metab. 2013; 27 (3): 333–43. DOI: https://doi.org/10.1016/j.beem.2013.02.006

7. Nesbit M.A., Hannan F.M., Howles S.A., et al. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. N Engl J Med. 2013; 368 (26): 2476–86. DOI: https://doi.org/10.1056/NEJMoa1300253

8. Wilhelm S.M., Wang T.S., Ruan D.T., et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016; 151 (10): 959–68. DOI: https://doi.org/10.1001/jamasurg.2016.2310

9. Gribeler M.L., et al. Secular trends in the incidence of primary hyperparathyroidism over five decades. Bone. 2016; 73: 1–7.

10. Miller P.D., Bilezikian J.P. Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res. 2002; 17 (Suppl 2): 98–102.

11. Albright F., Aub J.C., Bauer W. Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. JAMA. 1934; 102: 1276–87.

12. Mokrysheva N.G., Eremkina A.K., Mirnaya S.S., Krupinova J.A., et al. The clinical practice guidelines for primary hyperparathyroidism, short version. Problemi Endocrinologii [Problems of Endocrinology]. 2021; 67 (4): 94–124. DOI: https://doi.org/10.14341/probl12801 (in Russian)

13. Naji Rad S., Deluxe L. Osteitis fibrosa cystica. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.

14. Misiorowski W, Bilezikian JP. Osteitis Fibrosa Cystica. JBMR Plus. 2020; 4 (9): e10403. DOI: https://doi.org/10.1002/jbm4.10403

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)